2024 Predictions for AI in the Pharmaceutical Industry

Artificial Intelligence Medication Adherence Patient Outcomes

As we move through 2024, artificial intelligence (AI) continues to progress at its quickened pace, unveiling a multitude of transformative possibilities within the pharmaceutical industry. Let’s take a deep dive into the top 5 AI predictions for 2024 that will redefine the landscape of drug manufacturing and shape the future of innovation and impact.

The Rising Tide of Precision Medicine

Gene therapy, a transformative approach, is set to redefine the treatment landscape by addressing the root causes of diseases at the genetic level. This revolutionary technique holds the potential to correct, replace, or enhance faulty genes, offering personalized and targeted treatment. Concurrently, genetic testing provides a comprehensive understanding of an individual’s genetic makeup. This intricate knowledge not only facilitates early disease detection but also tailors treatment plans based on genetic predispositions, marking a significant leap towards more precise and effective healthcare strategies. As the synergy between gene therapy and genetic testing continues to evolve, 2024 promises a new era in precision medicine, where individualized care is at the forefront of medical advancements.

Integrating Generative AI

Generative AI, a subset of machine learning, has unparalleled ability to create new and innovative content autonomously. In the context of pharma, this spans everything from drug discovery and development to marketing strategies to patient education resources. 75 percent of leading healthcare companies are already experimenting with or planning to scale Generative AI across the enterprise.

The adaptive nature of AI  allows for synthesizing diverse and contextually relevant information, contributing to more effective communication strategies. It holds the potential of democratizing knowledge by making information more accessible, enhancing interoperability, and facilitating more communication.

RELATED: Learn how to leverage AI to build a best-in-class patient support  program >>

Solving for Health Equity with Tech

Health inequality within the healthcare system refers to disparities in access, quality, and outcomes of healthcare services among different populations. These inequities can arise from various factors, including socioeconomic status, race, ethnicity, geographic location, gender, and education. Individuals from marginalized or underserved communities often face barriers to accessing healthcare, leading to delayed diagnoses, inadequate treatment, and poorer health outcomes.

Addressing health inequality involves implementing policies and systemic changes to eliminate these disparities and ensure equitable access to healthcare for all individuals. Data analytics and AI contribute by identifying and prioritizing patients at-risk of health disparities and guiding the development of targeted interventions tailored to specific individuals.

By leveraging technology as an equalizing force, we not only break down traditional barriers but also pave the way for a more patient-centric system.

Continued Remote Monitoring of Patients

The repercussions of the pandemic continue to persist into 2024. The accelerating trend of adopting mobile apps and specialized devices for patient monitoring reflects a shift towards more accessible and efficient healthcare solutions.

As the healthcare ecosystem increasingly relies on these diverse data sources, a pressing need for robust data strategies emerges. Both pharmaceutical sponsors and Contract Research Organizations (CROs) must navigate the evolving terrain of distributed clinical trials and harness the power of cloud computing and meticulous data governance.

This shift not only ensures the seamless collection and analysis of patient data but also signifies a departure from conventional approaches, heralding an era where technology plays a pivotal role in reshaping patient care, clinical research, and the overall landscape of healthcare delivery.

Increasing Privacy Regulations and Cookie Depreciation

The dual challenges of increasing privacy regulations and the depreciation of cookies are reshaping the terrain for targeted patient initiatives. The impact extends beyond just targeting, though, and into measuring audience quality, office visits, and patient new starts where often only a fraction of data is captured.

In response, a transformative approach comes in identity resolution, a solution to cookieless marketing that connects identifiers across digital touchpoints into a single consumer identity. By combining first-party, second-party, and third-party data, identity resolution addresses privacy concerns and significantly enhances measurement capabilities, linking impressions to de-identified individuals and medical claims data.

When choosing a third-party vendor though, ensure you have robust privacy and security measures in place. Understanding best practices for HIPAA compliance, security, privacy and legal and encryption is critical.

AllazoHealth’s Commitment to Data Protection

AllazoHealth’s AI platform securely and compliantly uses identified patient data to determine risk factors for every individual patient and the optimal channels, content, timing, and cadence for them, meeting them where they are and supporting them in exactly the way they need to be supported.

AllazoHealth’s AI solution is fully HIPAA compliant to guarantee the highest level of patient data protection. The platform uses a secure HIPAA compliant infrastructure based in Azure. A third-party monitors security for any potential security risks. Using this industry best practice, AllazoHealth is helping to ensure an unbiased evaluation of the system.

AllazoHealth also operates within a SOC-2 compliant environment. The AI platform only sends and receives encrypted data between AllazoHealth and customers to safeguard patient and customer data in terms of HIPAA compliance, and patient consent and authorization. It does not interact directly with patients; instead, the AI uses patient information sourced solely from pharmaceutical companies whose patients have consented to provide data while enrolling in their PSP programs.

This disruption, driven by the industry’s shift away from cookies, paves the way for more accurate and meaningful metrics, providing pharma brands and PSPs an opportunity to navigate a future of safer, more effective, and measurable patient strategies.

Charting the Future of Healthcare

The dive into the top 5 predictions for 2024 has unveiled a future where precision medicine, Generative AI, health equity solutions, remote patient monitoring, and identity resolution converge to redefine healthcare. This year holds the promise of a healthcare landscape that prioritizes not just treatment but a holistic picture of patient care, marking the dawn of a new era in healthcare innovation and impact.

As we move forward, AllazoHealth emerges as the comprehensive AI solution, driving innovation, efficiency, and measurable success in the pharmaceutical industry’s pursuit of improved patient outcomes through therapy initiation and adherence.

Want to learn more?

Discover how AllazoHealth’s AI platform can personalize your patient support programs and omni-channel marketing, driving engagement, transforming health outcomes, and increasing operational efficiency. Request a demo today at AllazoHealth.com

eBook: Why Pharma Marketers Need Artificial Intelligence Now